Charles P. Waite Jr.

Background

Mr. Charles P. Waite, Jr., known as Chad, serves as the Managing Director and Partner at OVP Venture Partners. Mr. Waite joined OVP Venture Partners in 1987 and focuses on investments in the digital biology, network security, and drug discovery sectors. He has been Vice President of Northwest Venture Services Corp. since 1987. He has more than 25 years of experience in both the management and investment sides of emerging growth companies. He has sector expertise in digital ... technology, digital biology, network security, and life sciences sectors. He served as General Partner of Olympic Venture Partners II, L.P.; Olympic Venture Partners III, L.P.; Olympic Venture Partners IV, L.P. and Olympic Venture Partners V, L.P. From 1983 to 1987, Mr. Waite served as a General Partner at Hambrecht & Quist Venture Partners, where he focused on investments in information technology and life sciences. He served at Loudeye Corp. and Terumo BCT, Inc. From 1977 to 1981, he served as a Cardiovascular Products Specialist at Cobe Laboratories, Inc. Prior to that, Mr. Waite was in marketing and sales management at Cobe Laboratories, Inc. in its cardiovascular medical products division. Mr. Waite serves as the Chairman of Loudeye Technologies. Mr. Waite serves as a Director of GenoLogics, NanoString, Groove Biopharma Corporation, Adapx Inc., Verdezyne, Inc., CODA Genomics and Oncofactor Corporation. He serves as a Member at the OHSU BSIF Advisory Board and a Member at the University of Washington's Tech Transfer Advisory Board. He has been a Director of Limerick BioPharma, Inc. since July 15, 2009 and NanoString Technologies, Inc since July 2004. He is a member of the Oregon Health Sciences University (OHSU) BSIF Advisory Board and a member of the University of Washington's Technology Transfer Advisory Board. Mr. Waite serves as Director of The Technology Alliance. He serves as a Director of GenoLogics Life Sciences Software Inc. Mr. Waite serves as a Board Observer of Orb Networks, Altus Networks, and Serengeti. Mr. Waite serves as a Trustee at Kenyon College. He serves as a Director of Signalsoft Corporation since May 1997. He serves as Director of Talyst, Inc. Mr. Waite served as a Director of Symform, Inc. He served as a Director of Complete Genomics Inc. since March 2006. He served as Director of Napera Networks Inc. He served as Director of Allozyne, Inc. since November 4, 2005. Mr. Waite served as a Director of Returns Online, Inc., Accelerator Corporation, WatchGuard Technologies Inc., Seattle Genetics Inc., Action Engine Corporation and 4thpass Inc. He served as a Director of Theatrix Interactive, Inc.; Safeharbor Knowledge Solutions; Plectix BioSystems, Inc.; Acylin Therapeutics, Inc.; and Airgo Networks, Inc. He served as a Director of Rosetta Inpharmatics, Inc., since June 1997; and Verity Inc. since May 1988. Mr. Waite served as a Director at Integrated Diagnostics Inc. (formerly Homestead Clinical Corporation) and National Venture Capital Association. Mr. Waite holds an M.B.A. from Harvard University and an A.B. in History from Kenyon College.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.